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Abstract Exogenous oxidants appear capable of initiating both
proliferative and death signals, but the role of endogenous ox-
idants in either tumorigenesis or tumor suppression is unclear.
We found that expression of the NAD(P)H oxidase adapter
p47phox was suppressed in human colon carcinoma specimens
relative to adjacent normal colon. Overexpression of p47phox
increased apoptosis in colon cancer cell lines independent of
p53 and mismatch-repair competency. p47phox was found to in-
teract with the c-Abl adapter Abl interactor-1 (ABI-1), and
p47phox coprecipitated with both ABI-1 and c-Abl. Ectopic ex-
pression of p47phox in colon cancer cells increased oxidant pro-
duction with phosphorylation and activation of nuclear c-Abl
and consequent apoptosis. Colonic epithelial p47phox may be
speci¢cally targeted to a c-Abl-containing complex that serves
a physiologic tumor suppressing function.
/ 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Reactive oxidant species have long stood accused of pro-
moting tumor formation, largely through mutagenic events
which accompany direct DNA base and sugar modi¢cation
and strand breaks [1]. Indeed, oxidant-induced apoptosis has
generally been linked to induction of p53 as a response to
such broad DNA damage [2,3]. More recently, endogenously
produced oxidants have been recognized as mitogenic signal-
ing agents, providing an additional pathway by which reactive
oxidants may facilitate cell transformation. Consistently, an
NAD(P)H oxidase has been implicated as the source of these
mitogenic oxidants. The proliferative e¡ects of angiotensin II,
for instance, can be blocked by treatment with antisense oli-
gonucleotides for p22phox [4], and overexpression of the phag-
ocyte oxidase paralog Nox1 (Mox1) transforms cells [5].
Although much is known about the molecular events sur-
rounding colon carcinogenesis, a speci¢c role for oxidants has
not been identi¢ed. Normal human colon appears to express
signi¢cant levels of the NAD(P)H oxidase cytochrome b558,
consisting of p22phox and gp91phox [6], suggesting a potential
role for this oxidase in colon tumorigenesis. In both phago-
cytic and non-phagocytic cells, physiologic activation of the
NAD(P)H oxidase appears to require the signal-receiving
adapter p47phox [7,8]. In the present study, we found that
normal colon indeed expressed p47phox, but surprisingly, ex-
pression of p47phox in colon carcinoma specimens was de-
creased relative to adjacent normal colon tissue. Overexpres-
sion of p47phox by colon carcinoma cell lines increased
apoptosis rates, suggesting a tumor suppressing rather than
promoting role of endogenous oxidants. p47phox-derived oxi-
dants appear to activate nuclear c-Abl in a p53-independent
mechanism of cell death.
2. Materials and methods
2.1. Quantitative RT-PCR
Total RNA was extracted from eight unselected colon carcinoma
resection specimens and adjacent normal colon using Trizol (Gibco).
A truncated p47phox cDNA mimic was created by removal of a 180
base BglII fragment, and p47phox expression was assessed using an
RT-linked competitive PCR assay [8].
2.2. Plasmid and adenoviral construction
All PCR ampli¢cations for subcloning or mutagenesis were per-
formed with Pfu Turbo (Stratagene). Ad-p47 and Ad-lacZ were con-
structed previously [9]. Ad-p47(W193R) was constructed using the
AdenoX system (Clontech). The yeast shuttle vectors pGBKT7-p47
and pGBKT7-p47(1^298) were previously constructed [9]. Trunca-
tions of p47phox were PCR ampli¢ed between EcoRI and SalI sites
with appropriate stop codons inserted and ligated into pGBKT7.
p47(S303,304,328D) was derived by sequential PCR mutagenesis of
wild type p47phox, followed by subcloning into pGBKT7. pGEX-p47
and pGEX-p47(1^298) were derived by ampli¢cation of p47phox be-
tween EcoRI sites and ligation into pGEX-2TK. Full-length Abl in-
teractor-1 (ABI-1) was recovered from a library clone and subcloned
into the EcoRI and SalI sites of pCIneo-FLAG, with frame correc-
tion. All mutations and constructs were con¢rmed by sequencing.
2.3. Apoptosis assays and oxidant production
Rapidly growing Caco-2 and SW48 cells were trypsinized and in-
noculated with adenoviruses (MOI=100:1) immediately after replat-
ing. Transgene expression was 50^70% as assessed by lacZ expression.
After 24 h, media was replaced and after another 24 h, apoptosis was
assessed. STI571 (gift of Novartis Pharma) was used at 10 WM for the
last 24 h. Mono- and oligonucleosomal DNA fragments were detected
with a cell death sandwich ELISA kit (Roche). Cell cycle analysis was
determined 24 h after addition of adenoviruses by £ow cytometry with
propidium iodide [10]. Oxidant production was assessed with 2P,7P-
dichloro£uorescein-diacetate (10 WM) using £ow cytometry [8].
2.4. Yeast two-hybrid screening and interaction assay
A human endothelial cell library was previously constructed [9].
S. cerevisiae strain AH109 (Clontech) was stably transformed with
pGBKT7-p47(1^298) prior to large scale library transformation using
lithium acetate. Colonies surviving auxotrophic selection for bait vec-
tor (tryptophan), prey vector (leucine), and interaction (both histidine
and adenine) were tested for lacZ expression. Single clones from pos-
itive colonies were retested, and library plasmids from positives were
0014-5793 / 03 / $22.00 L 2003 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
doi:10.1016/S0014-5793(03)00262-X
*Corresponding author. Fax: (1)-214-857 0340.
E-mail address: lance.terada@med.va.gov (L.S. Terada).
1 Nucleotide sequence data reported are available in GenBank
database under accession # AF540955.
FEBS 27121 28-3-03
FEBS 27121 FEBS Letters 540 (2003) 195^200
passaged through E. coli, transformed into AH109 yeast, and mated
to bait-containing Y187 yeast for con¢rmation of interaction. Inter-
action of ABI-1 with p47 truncations was tested by transformation of
the p47 truncations into Y187, followed by mating with ABI-1-trans-
formed AH109. Diploids were assessed for lacZ expression with a
¢lter lift assay. ABI-1 was not an autonomous transactivator.
2.5. Glutathione S-transferase (GST) pulldown
GST, GST-p47, and GST-p47(1^298) were produced as previously
described [9] and assessed by Coomassie. Full-length ABI-1 was in
vitro translated from pAD-GAL4-ABI-1 with 15 WCi [35S]methionine
(TNT Quick Coupled, Promega), and 5 Wl of translation was added to
each binding reaction. After extensive washing, products were ana-
lyzed by autoradiography.
2.6. Immunoprecipitation
Caco-2 or Fx-293 (Fx) cells infected with Ad-p47 or Ad-lacZ and/or
transfected with pCINF-ABI-1 were lysed for 30 min at 4‡C in 20 mM
Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 1%
Triton X-100, 1 mM L-glycerophosphate, 1 Wg/ml leupeptin, and
1 mM phenylmethylsulfonyl £uoride (PMSF), then sonicated for 5 s
and centrifuged at 19 720Ug for 20 min. Following preclearing, com-
plexes were immunoprecipitated with anti-c-Abl (Santa Cruz) or anti-
p47 (Santa Cruz) and immunoblotted with anti-c-Abl, anti-p47 (rabbit
polyclonal, kind gift of Dr. Bernard Babior), anti-FLAG (M2, Sig-
ma), or anti-phosphotyrosine (Upstate).
2.7. c-Abl activity
c-Abl activity was assessed by autophosphorylation of immunopre-
cipitated c-Abl [11] in kinase bu¡er (10 mM Tris, pH 7.6, 5 mM
EDTA, 130 mM NaCl, 1% Triton X-100, and protease inhibitors)
containing 1 mM cold ATP and 10 WCi [Q-32P]ATP for 30 min at
30‡C. Nuclear and cytoplasmic c-Abl were separated [12] following
lysis in cold lysis bu¡er (1 mM EGTA, 1 mM EDTA, 10 mM KCl,
2 mM MgCl2, 10 mM L-glycerophosphate, 25 mM HEPES, 1 mM
DTT, 0.05% Igepal CA630, 2 mM PMSF, 100 Wg/ml leupeptin, 100
Wg/ml aprotinin, and 0.5 mM Na3VO4) for 10 min, Dounce homog-
enization, and collection of nuclear fraction spun through a 1 M
sucrose cushion at 1600Ug for 15 min. The cytoplasmic fraction
was further clari¢ed with a 150 000Ug spin for 30 min.
3. Results and discussion
3.1. Overexpression of p47phox increases colon carcinoma
cell death
We found a consistent decrease in the expression of p47phox
in colon carcinoma specimens compared to adjacent normal
colon tissue, with seven of eight carcinomas displaying re-
duced p47phox transcript levels (Fig. 1). Adenoviral delivery
of wild type p47phox increased apoptotic death of both
Caco-2 and SW48 colon carcinoma cell lines (Fig. 2a,b), sug-
gesting a possible tumor-suppressive role for p47phox in human
colon tissue. In contrast, p47(W193R) had no e¡ect on apo-
ptosis. This latter mutant has been shown to lack binding
function of the ¢rst p47 SH3 domain, a function critical to
assembly of the oxidase [8,13]. Overexpression of p47phox also
increased oxidant production (Fig. 2c) and cell cycle exit of
Caco-2 cells into an apoptotic sub-Go fraction (Fig. 2d). The
antioxidant NAC prevented p47-induced cell death without
a¡ecting baseline rates of cell death, and the p47(W193R)
mutant decreased the sub-Go fraction below baseline levels,
also consistent with an oxidant-dependent pro-apoptotic e¡ect
of p47phox.
The mechanism by which p47phox increases oxidant produc-
tion in Caco-2 cells is not clear, but may involve assembly of a
traditional NADPH oxidase complex. RT-PCR of Caco-2 cell
RNA between coding bases 1157^1636 demonstrated expres-
sion of the principal cytochrome b558 subunit, gp91phox, and
sequencing of the PCR fragment revealed 100% nucleotide
identity. This ¢nding is consistent with expression of the
NADPH oxidase cytochrome by normal human colon [6].
Caco-2 cells have also recently been found to express the
two other principle oxidase subunits, p22phox and p67phox
[14]. Alternatively, Caco-2 cells have been shown to express
the paralogous NOX1, which requires an adapter protein such
as p47phox for activation [15], although this latter cytochrome
appears to transduce growth rather than death signals when
ectopically expressed in Caco-2 cells [5].
3.2. p47phox associates with ABI-1
To identify a potential mechanism for the induction of ap-
optosis by p47phox, we screened a human library for p47-in-
teracting partners using a truncated p47phox [p47(1^298)] lack-
ing the autoinhibitory C-terminus. Truncation of this region
appears to open domains of p47phox necessary for binding
function [16]. We retrieved a cDNA encoding the c-Abl adapt-
er ABI-1 (e3B1/SSH3BP1), and con¢rmed the interaction in
yeast mating experiments (not shown). The cDNA includes
the full coding region of ABI-1 and reveals a presumed splice
variant (GenBank accession # AF540955). Compared with
the longest reported transcript (GenBank # NM005470), the
predicted protein lacks amino acid residues 155^159 and 274^
Fig. 1. p47phox transcript levels are decreased in colon carcinoma.
Total RNA from tumor and adjacent normal colon in resection
specimens was subjected to quantitative RT-PCR analysis. Top pan-
el shows representative competitive analysis, with authentic p47phox
band migrating slower than truncated mimic. p47phox transcript lev-
els per Wg total RNA were decreased in tumor specimens relative to
adjacent normal colon (P6 0.05, paired t-test). Horizontal bars in
lower panel represent group means.
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300 and contains a single nucleotide polymorphism (T515C,
encoding L172P). A direct interaction between p47(1^298)
and, to a lesser extent, full-length p47phox, was demonstrated
using a GST pulldown assay (Fig. 3a). Yeast mating studies
revealed an interaction between ABI-1 and the tandem SH3
domains of p47phox [p47(153^286), Fig. 3b]. Speci¢cally, a
weak interaction between ABI-1 and the second p47 SH3
domain [p47(223^286)], and a robust interaction with the ¢rst
p47 SH3 domain [p47(153^219)] was reproducibly demon-
strated. Interestingly, ABI-1 also interacted with the ¢rst
p47 SH3 region in which the tryptophan bridge of the SH3
binding surface was disrupted [p47(153^219;R193)], suggest-
ing an alternate binding site contained within p47(153^219),
and perhaps utilizing a mechanism independent of the classi-
cal SH3^polyproline helix interaction. As further evidence
that the ABI-1 binding site was not an artifact caused by
arti¢cial p47 truncations, we demonstrated an interaction be-
tween ABI-1 and p47(S303,304,328D) (Fig. 3b). This latter
full-length mutant mimics phosphorylation of three critical
serines, and appears to induce unmasking of the tandem
SH3 regions [16]. Finally, in Fx cells, FLAG-ABI-1 speci¢-
cally coprecipitated with p47phox (Fig. 3c).
ABI-1 is an ubiquitous protein, well-expressed in human
colon [17], and is able to mediate both pro- and anti-prolifer-
ative signals. It associates with PDGF and EGF receptors via
Eps8 [17], and transduces growth signals distal to Ras [18].
Conversely, overexpression of ABI-1 suppresses ¢broblast
growth [17], and overexpression of its mouse homolog Abi-1
inhibits v-Abl-induced transformation and ERK activation
[19,20]. Not surprisingly, its binding partner c-Abl also acts
as a molecular switch for cell fate, mediating both growth and
death signals. Growth factors such as PDGF and EGF acti-
vate c-Abl [21], and the fusion protein BCR-ABL is a well
known oncogene; however, overexpression of c-Abl induces
Fig. 2. p47phox overexpression increases colon cancer cell apoptosis. a: Caco-2 cells were infected (MOI=1:100) with either Ad-lacZ or Ad-p47
for 24 h, and examined with phase contrast microscopy (4U). Compared with the Ad-lacZ-infected cells (left panel), Ad-p47-infected cells dem-
onstrated a number of condensed, highly refractile cells. b: Top panel shows immunoblot with anti-p47 of Caco-2 cells infected with Ad-lacZ,
Ad-p47, or Ad-p47(W193R). DNA fragmentation, assessed by sandwich ELISA, increased in Caco-2 and SW48 cells 24 h after infection with
Ad-p47 (*P6 0.05 compared to control). Infection with Ad-p47(W193R) had no e¡ect compared to control, but decreased DNA fragmentation
in SW48 cells compared to Ad-lacZ-infection (P6 0.05). c: Oxidant production, measured as dichloro£uorescin (DCF) £uorescence, was as-
sessed in Caco-2 cells after 24 h exposure to respective adenoviruses. Oxidant production increased after infection with Ad-p47 but not Ad-
lacZ or Ad-p47(W193R) (*P6 0.05 compared to control). d: Cell death was also assessed in Caco-2 cells after 24 h infection with respective vi-
ruses by the appearance of cells in the sub-G0 cell cycle fraction. Infection with Ad-p47 increased exit of cells into the sub-G0 fraction
(*P6 0.05 compared to Ad-lacZ). Treatment of Ad-p47-infected cells with NAC (5 mM, pH adjusted, present for the ¢nal 16 h) decreased the
sub-G0 fraction back to baseline levels (**P6 0.05 compared to Ad-p47 without NAC), and infection with p47(W193R) decreased this value
below baseline (*P6 0.05 compared to lacZ).
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apoptosis [22], and endogenous c-Abl is required for apoptosis
precipitated by DNA damage [23]. Neither ABI-1 nor c-Abl is
presently thought to participate in colon tumorigenesis or
tumor suppression.
3.3. p47phox overexpression increases activation of c-Abl
Because high levels of exogenous oxidants can activate and
phosphorylate c-Abl [12,24], we next asked whether p47phox
could mediate activation of c-Abl. We found ¢rst that endog-
enous c-Abl speci¢cally coprecipitated with overexpressed
p47phox (Fig. 4a), consistent with simultaneous binding of
ABI-1 with p47phox and c-Abl. In addition, overexpression
of p47phox increased tyrosine phosphorylation of endogenous
c-Abl, whereas p47(W193R), which binds ABI-1 (Fig. 3b) but
does not support oxidant production (Fig. 2c), decreased
c-Abl phosphorylation (Fig. 4b). Finally, overexpression of
wild type p47phox increased whereas p47(W193R) decreased
c-Abl activity (Fig. 4c). The p47-dependent increase in c-Abl
activity was found predominantly in the nuclear fraction (Fig.
4d), consistent with the proposed cytostatic and apoptotic role
of nuclear as opposed to cytoplasmic c-Abl [25^27]. Indeed,
the Abl kinase inhibitor STI571 decreased p47-induced apo-
ptosis, while having no e¡ect on baseline apoptosis rates (Fig.
5). Recently, oxidants were shown to activate cytoplasmic, not
nuclear, c-Abl to induce apoptotic death in COS7 cells [12]. In
this latter study, however, cytoplasmic c-Abl was activated in
response to a high dose (1 mM) of exogenous oxidants over
15 min, and the response in our experiments to a presumably
lower level of site-directed, endogenous oxidants may di¡er.
Alternatively, activated cytoplasmic c-Abl may translocate
into the nucleus during certain conditions such as cell attach-
ment [28], and our observations taken at a later stage may
re£ect a similar nuclear importation.
While apoptosis resulting from a bolus of exogenous oxi-
dants appears to require the tumor suppressor p53 [2,3], we
found that p47phox increased apoptosis in the p53-de¢cient
Caco-2 cell line, again suggesting a di¡erent response to exog-
enous as opposed to endogenous oxidants. The lack of p53-
dependence is consistent with involvement of c-Abl, since
overexpression of c-Abl or activation of c-Abl by cisplatin
Fig. 3. ABI-1 binds p47phox. a: Direct binding of ABI-1 to p47phox was assessed by a GST pulldown assay. [35S]Methionine-labelled ABI-1
bound to GST fusions of both full-length p47phox and, more avidly, p47(1^298), but not to GST. b: AH109 yeast transformed with GAL4-AD-
ABI-1 were mated with Y187 yeast transformed with GAL4-BD-p47 truncations, as indicated. Diploids were replated and lacZ expression of
lifted colonies is shown. ABI-1 interacted primarily with a region coinciding with the ¢rst SH3 domain [p47(153^219)], despite disruption of the
SH3 surface [p47(152^219;R193)]. ABI-1 also interacted with an unfolded form of full-length p47phox [p47(S303,304,328D)], and weakly with a
region corresponding to the second SH3 domain [p47(223^286)]. Representative of three experiments. c: Fx cells were transfected with pCINF-
ABI-1 and 24 h later infected with Ad-p47. After a subsequent 24 h, p47 was immunoprecipitated and blots were probed with anti-FLAG for
FLAG-ABI-1 (top), then anti-p47 for p47phox (bottom).
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mediates cell death independent of p53 [29,30]. This latter
c-Abl-dependent death pathway, however, requires intact mis-
match-repair capacity, speci¢cally the MLH1 gene product
[29]. Interestingly, the apoptotic in£uence of p47phox is mani-
fest in SW48 colon cancer cells (Fig. 2b), which are p53wt but
de¢cient in MLH1 expression, suggesting that neither p53
induction nor mismatch-repair competence are absolutely re-
quired for p47-dependent apoptosis. These two death path-
ways may be duplicative with only one required to trigger
apoptosis. Alternatively, p47phox may initiate a novel, c-Abl-
dependent death pathway which does not require DNA dam-
age response elements such as p53 and MLH1. Such a mech-
anism may be consistent with the physiologic death of di¡er-
entiated colonic epithelial cells which normally have not
sustained DNA damage, and may explain how the loss of
p47phox contributes to tumorigenesis.
From our limited clinical observation, it is not possible to
establish a ¢rm causative link between colon tumorigenesis
and the loss of expression of p47phox. However, it is notewor-
thy that genetic de¢ciency of the phagocyte oxidase (chronic
granulomatous disease) due to loss of function mutations in
p47phox or gp91phox has been estimated to confer a 13.8-fold
increase in the relative risk of acquiring cancer [31], and cells
lacking gp91phox are resistant to camptothecin-induced apo-
ptosis [32]. Conversely, the pro-apoptotic e¡ects of p47phox
may also indicate an inseparable proliferative role for the
NAD(P)H oxidase. Indeed, a number of oncogenes, typi¢ed
by c-myc, Ras, and the viral E1A, initiate tightly coupled
proliferative and apoptotic events, the latter of which can
Fig. 4. Overexpression of p47phox activates endogenous c-Abl. a: Endogenous c-Abl from Caco-2 cells was immunoprecipitated with overex-
pressed p47phox (third lane). c-Abl was not recovered with irrelevant antisera (¢rst lane) or with anti-p47 in the absence of overexpressed p47
(second lane). b: Caco-2 cells were infected with the indicated viruses for 24 h, and endogenous c-Abl was immunoprecipitated. Infection with
Ad-p47 increased, whereas infection with Ad-p47(W193R) decreased, tyrosine phosphorylation of c-Abl, compared with Ad-lacZ-infected cells.
Representative of two experiments. c,d: Activation of c-Abl was assessed as autophosphorylation of immunoprecipitated c-Abl, 24 h after infec-
tion with the indicated viruses. Ad-p47 increased total (c) and nuclear (d) c-Abl activity. Cytosolic c-Abl activity did not change. Representative
of three experiments.
Fig. 5. Caco-2 cells were infected with Ad-lacZ or Ad-p47, and then
incubated with STI571 (10 WM) for 24 h. Ad-p47 increased apopto-
sis compared to Ad-lacZ (*P6 0.05), and STI571 decreased apopto-
sis rates in Ad-p47 but not Ad-lacZ-infected cells (**P6 0.05 com-
pared to Ad-p47 without STI571 treatment).
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only be gainsaid by autocrine survival signals [33]. Accord-
ingly, oxidants, ABI-1, and c-Abl all appear capable of medi-
ating both growth and death signals in di¡erent contexts.
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